Bcl-xL Antibody (016) [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-89507R
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunoprecipitation, Western Blot
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 016
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human Bcl-xL (Accession#: NP_612815.1; Met1-Arg212).
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Bcl-xL Antibody (016) [DyLight 550]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Bcl-xL
Long Name
B Cell Lymphoma/Leukemia x Long Form
Alternate Names
BclxL
Gene Symbol
BCL2L1
Additional Bcl-xL Products
Product Documents for Bcl-xL Antibody (016) [DyLight 550]
Product Specific Notices for Bcl-xL Antibody (016) [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...